Efnan Algın

11PUBLICATIONS
128CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 27, 2026
Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma Treated With Second-Line Immunotherapy.

|Jul 15, 2026
Clinicopathological Features of Intrahepatic Cholangiocarcinoma with Assessment of IDH1 Mutation: A Two-Center Retrospective Study.

|Jun 16, 2026
Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancer.

|May 27, 2026
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|May 04, 2026
A Machine Learning Framework for Prognostic Modeling in Stage III Colon Cancer.

|Feb 27, 2026
Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.

Baris Koksal, Hasan Cagri Yildirim, Deniz Can Guven

Pageof 2

Frequent Collaborators

5 joint publications

Öznur Bal

3 joint publications

Elif Sahin

3 joint publications

Doğan Uncu

3 joint publications

Hasan Çağrı Yıldırım